# A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People

> **NCT05227196** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 546 (actual)

## Conditions studied

- Healthy Volunteers
- Type 2 Diabetes

## Interventions

- **DRUG:** Semaglutide D Dose 1
- **DRUG:** Semaglutide D Dose 2
- **DRUG:** Semaglutide D Dose 3
- **DRUG:** Semaglutide Dose 4
- **DRUG:** Semaglutide Dose 5
- **DRUG:** Semaglutide Dose 6

## Key facts

- **NCT ID:** NCT05227196
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-04
- **Primary completion:** 2023-06-28
- **Final completion:** 2023-08-08
- **Target enrollment:** 546 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227196

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227196, "A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05227196. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*